Abstract 1500P
Background
Approximately 50% of deaths worldwide occur in an acute hospital setting. Doctors-in-training (DITs) experience death & dying in many forms and settings, and at every stage of their medical training. They often feel unprepared or unsupported when providing this care, which can cause significant distress. Yet, our experience is that DITs do not receive much, if any, specific training or support in approaching these events. The purpose of this study is to establish the training and education received by DITs in Cork University Hospital in dealing with death and explore the concept of spirituality in relation to their own experiences.
Methods
We performed a qualitative survey of DITs using a 27-question electronic survey. Participants answered questions regarding the prior training or education they had received relating to death and dying, their confidence in recognising and managing dying, and their opinion on the adequacy of the training or support available currently. A modified version of the Spiritual Wellbeing Scale (SWBS) questionnaire, a validated tool to provide an overall measure of perceived spiritual quality of life, was used to assess impact on spirituality.
Results
130 DITs responded to our survey (female=75). 67% disagreed or strongly disagreed (n=87) that they have received adequate training in relation to death & dying. Almost half did not feel confident discussing end-of-life care with patients or their families (n=63), and 69% (n=88) felt that support offered after the death of a patient was inadequate. The vast majority agreed or strongly agreed (n=124) that end-of-life care was important to the delivery of acute care. 71% (n=92) reported that the death of a patient had had a personal impact on them. The median Existential Wellbeing Score was 44 (range 24-59), indicating a moderate sense of life satisfaction. Of note, however, 49% (n=64) responded that they felt unsettled about their future.
Conclusions
Patient deaths frequently impact DITs. This survey highlights the importance of improving the training and supports available to DITs in dealing with death & dying. This has the potential to benefit both DITs, through better wellbeing, and their patients, by improving confidence and competence providing end-of-life care.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Cork University Hospital Medical Oncology Department.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1502P - Sexual dysfunction and quality of life in rectal cancer
Presenter: Fatih Kus
Session: Poster session 10
1503P - Spiritual needs in cancer patients: A cross-sectional study
Presenter: Diego Toloi
Session: Poster session 10
1546P - Use of ESMO-MCBS Scorecards in supporting funding decisions in private insurance
Presenter: Samantha Field
Session: Poster session 10
1547P - Time from approval to reimbursement of new cancer and non-cancer drugs: A comparative analysis between the US, England, Germany, and Switzerland (2011-2022)
Presenter: Camille Glaus
Session: Poster session 10
1548P - Real-world impact of the platinum chemotherapy shortage on advanced cancer patients
Presenter: Jacob Reibel
Session: Poster session 10
1549P - Accelerating access to innovative oncology drugs: Insights from France's early access reform
Presenter: Tess Martin
Session: Poster session 10
1550P - Addressing uncertainties of clinical value and improving access for newly authorised indications through DRUG-Access Protocol (DAP)-like platforms: Joint collection and evaluation of real-world evidence
Presenter: Sahar van Waalwijk van Doorn-Khosrovani
Session: Poster session 10
1551P - Breakthrough therapy cancer drugs and indications with FDA approval: Development time, innovation, trials, clinical benefit, epidemiology, and price
Presenter: Christoph Michaeli
Session: Poster session 10
1552P - Regulatory approval of novel immunotherapy for lymphoid neoplasm in the US, EU, and Japan
Presenter: Kensuke Matsuda
Session: Poster session 10
1553P - Access to EMA approved drugs in Europe, disparities across a border
Presenter: Orla Fitzpatrick
Session: Poster session 10